FIELD: abdominal conditions. SUBSTANCE: new active ingredient and constipation-treatment pharmaceutical composition based on this ingredient - dimeticone (dimethylpolysilixane) are provided. Composition has no usual adverse effects and can be used in treatment of problem patients: children, pregnant, etc. EFFECT: increased constipation treatment safety. 6 cl, 2 ex
Authors
Dates
2000-01-10—Published
1994-12-02—Filed